期刊文献+

奥曲肽抑制胃癌细胞系SGC-7901生长的实验研究 被引量:1

Inhibition Effect of Octreotide on the Growth of Gastric Carcinoma Cells SGC-7901
下载PDF
导出
摘要 目的 研究奥曲肽对胃癌细胞系SGC -790 1生长的抑制作用。方法 将奥曲肽注入胃癌细胞 ,采用四甲基偶氮唑蓝 (MTT )法测定细胞生长抑制效应 ,将3 H -胸腺嘧啶核苷 (3 H -TdR )掺入试验测定奥曲肽对胃癌细胞DNA合成的影响 ,显微镜下观察胃癌细胞形态变化 ,应用流式细胞仪 (FCM )检测细胞周期 ,并采用TRAPPCR -ELISA法对胃癌细胞端粒酶活性进行检测。结果 奥曲肽对胃癌细胞系SGC -790 1的生长及DNA合成均有抑制作用 ,显微镜下可见细胞变圆、变小、脱落 ,FCM检测结果显示奥曲肽作用后 ,G0 /G1期细胞比例增高 ,S期、G2 /M期细胞比例下降 ,端粒酶活性显著受抑制。结论 奥曲肽能明显抑制胃癌细胞系SGC -790 1的生长 ,形成G0 /G1期阻滞 。 Objective To study inhibition effect of octreotide on the growth of gastric carcinoma cells SGC-7901.Methods The gastric carcinoma cells were treated with octreotide.The effect of growth suppression on cells was evaluated by MTT assay.The effect of octreotide on DNA synthesis of gastric carcinoma cells was evaluated by 3H-thymidine( 3H-TdR)incorporation.Morphologic changes of gastric carcinoma cells were observed under microscope.Cell cycle was detected by flow cytometry(FCM).The activity of telomerase of gastric carcinoma cells was examined by TRAP PCR-ELISA.Results Octreotide obviously inhibited the growth and DNA synthesis of SGC-7901 cells.SGC-7901 cells became round,small,and exfoliating after treated with Octreotide.The FCM analysis showed that the number of gastric carcinoma cell of G 0/G 1 phase increased and the number of cell of S phase and G 2/M phase decreased.The activity of telomerase of gastric carcinoma cells was obviously inhibited.Conclusion Octreotide can obviously inhibit the growth of SGC-7901 cells,cause G 0/G 1 blocking and inhibit the activity of telomerase.
出处 《实用癌症杂志》 2003年第4期350-353,共4页 The Practical Journal of Cancer
关键词 胃癌 SGC-7901细胞系 奥曲肽 端粒酶 细胞周期 Octreotide Gastric carcinoma Cell cycle Telomerase
  • 相关文献

参考文献12

  • 1王强,吴清明,姜东升,李胜保.细针穿刺细胞端粒酶定量检测的应用价值[J].实用癌症杂志,2000,15(6):615-616. 被引量:5
  • 2王春晖,唐承薇,汤丽平.奥曲肽抑制肝癌生长的实验研究[J].中华医学杂志,2001,81(19):1194-1197. 被引量:42
  • 3吴清明,王强,谢国建,王小虎,李胜保,李晓斌.食管癌刷检、活检和手术标本端粒酶活性检测的比较[J].实用癌症杂志,2001,16(6):625-627. 被引量:5
  • 4黄瑾,余新婕,张玉兰,顾永清,何玲,周祖钊.消化道恶性肿瘤组织中端粒酶的检测及其意义[J].实用癌症杂志,2001,16(1):14-15. 被引量:3
  • 5Georgii-Hemming P,Stromberg T,Janson ET,et al. The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines[J]. Blood, 1999,93(5) : 1724.
  • 6Koizumi M,Onda M,Tanaka N, et al. Antiangiogenic effect of octreotide inhibits the growth of human rectal neuroendocrine carcinoma [J]. Digestion, 2002, 65 ( 4 ):200.
  • 7Kouroumalis E, Skordilis P, Thermos K, et al. Treatment of hepatocellular carcinoma with octreotide, a randomised controlled study[J]. Gut, 1998,42(3) :442.
  • 8O'Byrne KJ, Schally AV,Thomas A, et al. Somatostatin,its receptors and analogs,in lung cancer[J]. Chemotherapy,2001,47(Suppl 2):78.
  • 9Denzler B, Reubi JC. Expression of somatostatin receptors in peritumoral veins of human tumors [J]. Cancer1999,85(1) :188.
  • 10Cattaneo MG, Amoroso D, Gussoni G, et al. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines[J]. FEBS Lett, 1996,397(2--3) :164.

二级参考文献7

共引文献50

同被引文献2

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部